Standard Chem & Pharm Co. Ltd. (1720.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.95B |
| Enterprise Value | 12.25B |
| P/E Ratio | 10.82 |
| PEG Ratio | 5.41 |
| Price/Sales Ratio | 1.5 |
| Price/Book Ratio | 1.68 |
| Enterprise/Revenue | 1.37 |
| Enterprise/EBITDA | 5.19 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.22 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.16 |
Income Statement
| Revenue | 7.02B |
| Revenue/Share | 36.78 |
| Gross Profit | 2.91B |
| EBITDA | 1.8B |
| Net Income | 927.66M |
| Diluted EPS | 5.19 |
Balance Sheet
| Total Cash | 2.16B |
| Total Cash/Share | 11.01 |
| Total Debt | 970.3M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 2.67 |
| Book Value Per Share | 49.23 |
Price History
| 52-Week Change | 1.88 |
| 52-Week High | 60.55 |
| 52-Week Low | 53.09 |
| Moving Average 50 Days | 56.39 |
| Moving Average 200 Days | 56.73 |
Statistics
| Average Volume | 213,212 |
| Shares Outstanding | 196.57M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 3.62 |
| Payout Ratio | 0.36 |
| Last Split Factor | 11:10 |
| Last Split Date | July 23, 2026 |
AD
